Indraprastha Medical Corporation Ltd Faces Bearish Momentum Amid Technical Downgrade

Technical Momentum and Moving Averages Signal Bearish Outlook

Recent technical analysis reveals that Indraprastha Medical Corporation Ltd’s daily moving averages have turned bearish, indicating downward pressure on the stock’s price in the short term. The stock’s current price of ₹371.65 remains significantly below its 52-week high of ₹640.05, underscoring the challenges faced over the past year. The 52-week low stands at ₹342.35, placing the current price closer to the lower end of its annual trading range.

The bearish moving averages align with the broader technical trend change from mildly bearish to bearish, suggesting that the stock may continue to face resistance in regaining upward momentum. This is further corroborated by the weekly and monthly Bollinger Bands, which are mildly bearish and bearish respectively, indicating increased volatility and a tendency for the price to remain under pressure.

MACD and RSI Offer Mixed Signals

The Moving Average Convergence Divergence (MACD) indicator presents a nuanced picture. On a weekly basis, the MACD remains bearish, reinforcing the downward momentum. However, the monthly MACD is only mildly bearish, suggesting that while the short-term trend is negative, the longer-term momentum may not be as severe. This divergence between weekly and monthly MACD readings highlights the importance of monitoring the stock closely for potential trend reversals or further deterioration.

Relative Strength Index (RSI) readings on both weekly and monthly charts currently show no clear signal, hovering in neutral territory. This lack of a definitive RSI signal indicates that the stock is neither overbought nor oversold, leaving room for either a rebound or further decline depending on upcoming market catalysts and sector developments.

Additional Technical Indicators Paint a Complex Picture

The Know Sure Thing (KST) indicator offers a split view: mildly bullish on a weekly basis but mildly bearish monthly. This suggests short-term attempts at recovery may be offset by longer-term weakness. Similarly, Dow Theory assessments show a mildly bearish weekly trend contrasted by a mildly bullish monthly outlook, reinforcing the mixed signals from other oscillators.

On-Balance Volume (OBV) readings also reflect this duality, with weekly data mildly bearish but monthly data mildly bullish. This divergence between volume and price trends may indicate accumulation at lower levels, although confirmation is needed before investors can consider this a reliable sign of strength.

Performance Comparison with Sensex Highlights Underperformance

When compared with the broader market benchmark, the Sensex, Indraprastha Medical Corporation Ltd has underperformed over most recent time frames. The stock delivered a 3.45% return over the past week, outperforming the Sensex’s 1.08% gain. However, over the last month, the stock declined by 8.39%, significantly worse than the Sensex’s 0.85% loss.

Year-to-date, the stock has fallen 17.00%, compared to the Sensex’s 10.81% decline, and over the past year, it has dropped 15.05%, nearly double the Sensex’s 7.50% loss. Despite this recent underperformance, the stock’s long-term returns remain impressive, with a three-year gain of 321.71% versus the Sensex’s 21.61%, a five-year gain of 316.88% against the Sensex’s 48.99%, and a remarkable ten-year return of 605.22% compared to the Sensex’s 188.28%.

Mojo Score Downgrade Reflects Growing Caution

Reflecting the deteriorating technical and price momentum, MarketsMOJO downgraded Indraprastha Medical Corporation Ltd’s Mojo Grade from Hold to Sell on 30 January 2026. The current Mojo Score stands at 40.0, signalling a cautious stance for investors. This downgrade is consistent with the bearish technical trend and the stock’s recent price underperformance relative to the broader market and sector peers.

Investor Takeaway: Caution Advised Amid Mixed Technical Signals

Indraprastha Medical Corporation Ltd’s technical landscape is characterised by a clear shift towards bearish momentum, particularly in the short term, as evidenced by daily moving averages and weekly MACD readings. The absence of strong RSI signals and the mixed messages from KST, Dow Theory, and OBV indicators suggest that the stock is at a critical juncture where either a further decline or a technical rebound could materialise.

Investors should weigh the stock’s recent underperformance against the Sensex and its downgraded Mojo Grade before committing fresh capital. While the long-term returns remain robust, the current technical environment advises prudence, especially for those with shorter investment horizons or lower risk tolerance.

Monitoring the stock’s ability to break above key resistance levels near ₹374.40, today’s high, and observing any improvement in monthly MACD and Bollinger Band signals will be crucial for assessing potential trend reversals. Until then, the prevailing bearish momentum and technical caution warrant a conservative approach.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today